Close Menu

NEW YORK (360Dx) – A group of researchers led by the University of Arkansas has developed a photoacoustic (PA) platform called Cytophone to detect and destroy in vivo circulating tumor cells (CTCs) in patients with melanoma.

Spearheaded by Arkansas Nanomedicine Center lab director Vladimir Zharov, the team aims to commercialize the Cytophone technology through a startup within the next year.  

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.